Gérard A, Le Meins V, Maurer P, Witz B, Dopff C
Service des Maladies Infecteuses et de Réanimation Neurorespiratoire, CHU Brabois, Vandoeuvre-les-Nancy, France.
Pathol Biol (Paris). 1996 Feb;44(2):138-40.
The authors report a retrospective study of 35 patients treated with cefepime (Axepim). This patients were either hospitalized in a medical or in a surgical ICU or were febrile neutropenic patients. The non neutropenic group was put on cefepime for nosocomial pneumonia or miscellaneous sepsis. When recovered, Enterobacteriaceae were the most frequent pathogens. Clinical cure rate for the patients treated with cefepime was 83%. Cefepime is a safe and effective empirical treatment for serious infections and nosocomial infections in particular.
作者报告了一项对35例接受头孢吡肟(头孢匹姆)治疗患者的回顾性研究。这些患者要么在内科或外科重症监护病房住院,要么是发热性中性粒细胞减少患者。非中性粒细胞减少组因医院获得性肺炎或其他败血症接受头孢吡肟治疗。恢复后,肠杆菌科是最常见的病原体。接受头孢吡肟治疗患者的临床治愈率为83%。头孢吡肟是一种安全有效的经验性治疗方法,尤其适用于严重感染和医院获得性感染。